This dual mechanismsurgical restriction plus hormonal appetite suppressionaddresses weight loss from two independent angles, potentially achieving outcomes that surgery alone cannot reach
Moreover, some authors have suggested that hyperinsulinemia, hyperglycemia, and chronic inflammation typical of untreated DM would be risk factors for TC development and/or progression (Jee et al., 2005
These healthy fats help lower triglyceride levels and may reduce LDL (bad) cholesterol while supporting heart health overall
For most patients, tirzepatide is the right choice now, with retatrutide as a potential option in 2028 for those who need more or achieved inadequate results
Semaglutide drugs like Ozempic and Wegovy cost ~$1,000/month
A new study published in The Lancet Regional Health found that use of GLP-1 receptor agonists in the context of weight-loss treatment is associated with declines in lean (muscle) mass unless accompanied by targeted strength training interventions